register

News & Trends - Pharmaceuticals

Medicines Australia CEO voices policy and advocacy focus for 2024

Health Industry Hub | January 24, 2024 |

Pharma News: In this Health Industry Hub interview, Liz de Somer, CEO of Medicines Australia, acknowledged the top highlights that led to meaningful change in 2023, and voiced the key policy agenda for the new year.

The delayed government response to The New Frontier report was addressed, with a focus on organisations expressing disappointment due to the response mainly supporting recommendations already in progress.

The Health Technology Assessment (HTA) Review took centre stage, with concerns raised about transparency and progress against deadlines. The delayed consultation 2 opens for submissions in the week of 22 January with online and in-person workshops planned to take place throughout February 2024.

Looking ahead, the interview touched upon the potential impact of an early federal election on the HTA Review’s success. Ms de Somer shared insights into Medicines Australia’s strategic objectives and policy focus areas for 2024, emphasising the goals aimed at delivering significant impacts for both patients and the pharmaceutical industry.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Aussie medtech forges ahead, making inroads with new technology

Aussie medtech forges ahead, making inroads with new technology

Health Industry Hub | February 23, 2024 |

MedTech & Diagnostics News: Adelaide-based medical technology firm, LBT Innovations has successfully delivered its cutting-edge Automated Plate Assessment System (APAS) […]

More


News & Trends - Pharmaceuticals

Is the imposed PBS funding cap driving the migraine medicines shortage?

Is the imposed PBS funding cap driving the migraine medicines shortage?

Health Industry Hub | February 23, 2024 |

Pharma News: Australia finds itself grappling with an unparalleled shortage of migraine prevention medicines, leaving a significant impact on the […]

More


News & Trends - Pharmaceuticals

MSAC rejects Janssen's CAR T therapy despite clinical superiority, citing need for 'substantial price reduction'

MSAC rejects Janssen’s CAR T therapy despite clinical superiority, citing need for ‘substantial price reduction’

Health Industry Hub | February 23, 2024 |

Pharma News: The Medical Services Advisory Committee (MSAC) has deferred its decision on whether Janssen’s CAR T-cell therapy Carvykti (cilta-cel) […]

More


News & Trends - Pharmaceuticals

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Health Industry Hub | February 23, 2024 |

Pharma News: The Therapeutic Goods Administration (TGA) has granted approval for the first endometriosis treatment in 13 years. Gedeon Richter […]

More


This content is copyright protected. Please subscribe to gain access.